Tag: the war on (some) drugs

US Signs Deal That Will Allow Military Deployments to Ecuador

The Biden administration has quietly struck a deal with Ecuador to deploy troops to the country and patrol the waters off its coast to combat drug cartels, the Washington Examiner reported on Friday.

Select members of Congress were informed of the agreements on Wednesday during a closed-door briefing with Ecuadorian President Guillermo Lasso, who was in Washington to sign the deals.

The State Department did not publicize the agreements, but a State Department official confirmed the deals were signed in comments to the Examiner. The maritime deal will allow the US Coast Guard to patrol waters off Ecuador’s coast, an area where Colombian cartels transport cocaine.

The second agreement outlines the terms by which the US troops could be deployed to Ecuador, known as a status of forces agreement. The details of the agreement are not known, and it’s also unclear if it means a US troop deployment is imminent.

Keep reading

California Governor Signs Bills To Let Doctors Prescribe Psilocybin And MDMA If They’re Federally Rescheduled And To Change Marijuana Testing Rules

California Gov. Gavin Newsom (D) has signed a bill that would allow doctors to immediately start prescribing certain currently illicit drugs like psilocybin and MDMA if they’re federally rescheduled, and he also approved separate legislation to amend THC variance testing requirements for marijuana.

The governor signed off on the measures—which are just two of more than a dozen cannabis and drug policy reform proposals on his desk—on Saturday.

AB 1021, sponsored by Assemblymembers Buffy Wicks (D), Isaac Bryan (D) and Corey Jackson (D), says that, if the federal government reschedules any Schedule I drug under the Controlled Substances Act (CSA), California health professionals will automatically be able to legally prescribe and dispense it.

This could be especially relevant to the psychedelics psilocybin and MDMA, which have been designated as breakthrough therapies by the federal Food and Drug Administration (FDA) and are expected to be approved for medical use as early as next year.

Following a recent Phase 3 clinical trial, a peer-reviewed study published in the journal Nature last month found that treatment with MDMA reduced symptoms in patients with moderate to severe PTSD. The findings mean federal regulators could consider approving the drug for wider use as soon as next year.

Keep reading

SEALs, Other Navy Special Warfare Troops To Be Randomly Tested For Performance Enhancing Drugs

The Naval Special Warfare (NSW) Command will begin randomly testing its personnel for performance-enhancing drugs (PEDs), following allegations that such drugs are in widespread use among the Navy’s special warfare community.

Rear Adm. Keith Davids, the commander of NSW, announced the command will introduce incremental, random force-wide urinalysis testing starting in November.

“My intent is to ensure every NSW teammate operates at their innate best while preserving the distinguished standards of excellence that define NSW,” Rear Adm. Davids said in a Friday press statement.

NSW is most known for its Navy SEAL teams but the command is also responsible for training and deploying Special Warfare Combatant Crewmen and Explosive Ordnance Disposal technicians.

Illicit substances have been a persistent concern throughout the military, even in the special operations community. Some leaders have balked at testing regimens for performance-enhancing drugs because they are often highly specialized and costly and require contracting through a limited number of labs that do such work. The military services have done occasional tests when they perceive a problem with an individual service member, but they must get special permission from the Pentagon to do routine, random testing.

Keep reading

Exclusive video captures smoke shop raid in Philadelphia

Authorities across the region are cracking down on illegal marijuana operations.

Law enforcement raided a total of five smoke shops in Philadelphia and South Jersey.

Police said some of the shops were allegedly selling to minors.

Only the Action News Investigative Team was there as officers with the Philadelphia Police’s Narcotics Unit raided a home and smoke shop on the 6000 block of Lansdowne Avenue in Overbook on Monday.

This shop was one of three in the city raided for allegedly selling illegal marijuana products.

The other two are on the 2200 block of South 21st Street in South Philadelphia and the 7900 block of Verree Road in Fox Chase.

Police took out boxes of evidence from the Overbrook shop, and two men were arrested and taken away in handcuffs.

Keep reading

THE SCIENCE IS CLEAR: MARIJUANA IS SAFER THAN TOBACCO

Nearly twice as many Americans believe that smoking cigarettes is more hazardous to your health than smoking marijuana. They’re right.

Numerous studies assessing the long-term health impacts of cannabis smoke exposure belie the myth that marijuana is associated with the same sort of well established, adverse respiratory hazards as tobacco.

For example, federally funded research at the University of California, Los Angeles compared the lifetime risk of lung cancer among more than 2,000 long-term marijuana smokers, tobacco smokers, and non-smokers.

Investigators determined that those who regularly smoked cigarettes possessed a 20-fold higher lung cancer risk than non-smokers. Those who only smoked marijuana had no elevated risk.

“We hypothesized that there would be a positive association between marijuana use and lung cancer,” the study’s lead author explained. “What we found instead was no association at all, and even a suggestion of some protective effect.”

More recently, a team of health experts writing in the journal Chronic Obstructive Pulmonary Diseases reported that neither former nor current cannabis smoking “of any cumulative lifetime amount” was associated with COPD progression or development.

Other studies indicate that cannabis smoke and tobacco smoke aren’t equally carcinogenic and that subjects who exclusively smoke cannabis have less exposure to harmful toxicants and carcinogens than tobacco smokers. Some researchers have also theorized that cannabinoids’ anti-cancer activities may offset some of the harms otherwise associated with inhaling smoke.

According to the findings of recent paper published in the American Journal of Respiratory and Critical Care Medicine, “It is increasingly clear that cannabis has different effects on lung function [compared] to tobacco and the effects of widespread cannabis use will not necessarily mirror the harms caused by tobacco smoking.”

A separate review paper, published recently by researchers affiliated with the University of Arkansas, is even more blunt. “The data on marijuana contrast starkly with the consistent demonstration of injury from tobacco, the greatest legalized killer in the world today,” they concluded. “Any possible toxicity of marijuana pales in comparison.”

Keep reading

Despite Debunking, Rainbow Fentanyl Myths Continue

In 2022, fears erupted over “rainbow fentanyl,” brightly colored fentanyl pills that were said to be designed by drug traffickers to lure innocent children into taking opioids. Parents were warned to be on the watch for the pills—especially in their children’s Halloween candy stash.

A warning from the Drug Enforcement Agency (DEA) released last August warned that the increasing presence of brightly colored pills “appears to be a new method used by drug cartels to sell highly addictive and potentially deadly fentanyl made to look like candy to children and young people.”

“Rainbow fentanyl—fentanyl pills and powder that come in a variety of bright colors, shapes, and sizes—is a deliberate effort by drug traffickers to drive addiction amongst kids and young adults,” added DEA Administrator Anne Milgram.

However, it was startlingly easy to debunk panic over rainbow fentanyl. As it turns out, drug dealers have plenty of willing adult customers. So why would these they try to lure children, a customer base with no money of their own? And why would dealers give away valuable stock to do so?

“I’m skeptical that [dealers] would try to target children where there is not an existing market,” Sally Satel, an addiction psychiatrist and resident fellow at the American Enterprise Institute, told Reason‘s Lenore Skenazy in 2022. Considering the high risk of overdose in children, Satel added that “few would survive and come back for more.”

Just as there are adult reasons for vape companies to sell flavored vape pods, which were the subject of another panic, there are adult reasons for dealers to color their fentanyl—namely, to “brand [their] stuff.”

Keep reading

Give Small Business a Fighting Chance Against Mega Marijuana

The SAFE(R) Banking Act vote and the Biden administration’s review of the federal status of marijuana have garnered headlines and applause from many drug reform advocates and cannabis industry leaders. But without congressional action to protect small businesses, federal marijuana reform threatens to give an unfair advantage to a handful of national corporations while hobbling thousands of local farmers and neighborhood shopkeepers.

Under current law, state-licensed marijuana companies are denied the use of basic financial services. That means no checking accounts, no tax credits, no small business loans. For the cannabis industry’s emerging billion-dollar corporations, that’s not a problem. They’re able to expand and gobble up smaller companies (and their licenses) using private equity money and funding rounds in the hundreds of millions of dollars.

Small businesses can’t compete on that scale. Unless Congress acts, the Biden administration’s plan to merely reschedule marijuana is likely to supercharge the rise of national cannabis conglomerates while strangling local community-scale businesses.

This should be a bipartisan win-win. Support for small business and marijuana legalization are two rare issues where Republican and Democratic voters find common ground. A recent Gallup poll found Republican support for legalization now tops 51 percent, while 81 percent of Democrats want to end pot prohibition. Both parties compete to be seen as the one true BFF of Main Street mom-and-pops.

And yet party leaders on both sides are poised to embrace a lose-lose. In a study recently published by Ohio State University’s Drug Enforcement and Policy Center, we found that America’s $26 billion legal cannabis industry is quickly consolidating into the hands of a few well-financed national players. In 2018, the seven largest multistate cannabis companies accounted for only 3 percent of the legal industry’s annual revenue. By the end of 2022, that share had grown to nearly 18 percent.

If the trend continues, the cannabis industry might soon resemble America’s beer industry: a market dominated by a handful of global corporations with small businesses competing for an ever-shrinking slice of the pie.

Keep reading

The Truth About Ron DeSantis’ Fentanyl Horror Story

The second Republican debate of the 2024 presidential campaign cycle took place at the Ronald Reagan Presidential Library on Wednesday, and at various points throughout the night the topic turned to drug policy.

The candidates argued over the proliferation of fentanyl—the synthetic opioid significantly more potent than morphine or heroin that is often found mixed with other narcotics purchased on the black market. Specifically, the candidates squabbled over who would most aggressively weaponize the military and federal power in an attempt to prevent illicit fentanyl from reaching American shores.

Some of the candidates deployed anecdotes gleaned from the campaign trail of people whose loved ones died of fentanyl overdoses in order to justify increasingly oppressive drug policy. But Gov. Ron DeSantis’s example is much more complicated than he let on.

“In Florida, we had an infant, 18 months [old],” DeSantis said. “Parents rented an Airbnb, and apparently the people that had rented it before were using drugs. The infant was crawling, the toddler was crawling on the carpet and ingested fentanyl residue and died. Are we just going to sit here and let this happen, this carnage happen in our country? I am not going to do that.” As he has in the past, DeSantis used the story to illustrate the need for tougher drug and immigration policy, up to and including shooting people as they cross the border with Mexico.

DeSantis’s campaign did not respond to a clarifying question by press time, but he seemed to be referring to Enora Lavenir, the 19-month-old daughter of a French couple vacationing in Wellington, a small Florida town near West Palm Beach. The Lavenirs rented a four-bedroom house through Airbnb, where on August 7, 2021, Enora’s mother Lydie Lavenir found her unconscious and foaming at the mouth. Paramedics rushed the girl to the hospital, where she was pronounced dead.

Last year, the Lavenirs filed a wrongful death suit against Airbnb, the property’s owners, and the most recent previous renter. The lawsuit has since been amended to add additional defendants including HomeAway, the parent company of Vrbo, another home-rental service through which the prior tenant rented the house. According to the lawsuit, “the medical examiner detected a lethal level of Fentanyl in Enora’s blood and determined that her cause of death was acute Fentanyl toxicity. Toxicology readings indicated a quick death, ruling out the possibility that Enora came into contact with Fentanyl anywhere else but in the Airbnb rental.”

Contrary to DeSantis’s statement at the debate, the lawsuit does not claim that Enora was “crawling on the carpet and ingested fentanyl residue.” In fact, the suit does not speculate exactly how Enora came into contact with the drug; it merely alleges that Airbnb and Vrbo have “known for years that drug use is prevalent in [their] properties” and “that drugs, paraphernalia, and residue are frequently left behind in rentals, that there is a substantial risk of them being left behind, and that when they are left behind they pose a fatal risk to future guests, including children and infants.”

Keep reading

San Francisco Mayor London Breed Calls for Mandatory Drug Testing for Welfare Recipients

San Francisco Mayor London Breed proposed a plan which would require welfare recipients to undergo  drug testing and engage in treatment programs.

The announcement comes as the city deals with an average of three overdose deaths a day, Breitbart News reported. 

The new initiative would require those receiving County Adult Assistance Programs (CAAP) to be tested for drug use and participate in treatment programs, Fox News Digital reported.  

“San Francisco is a city of compassion, but also a city that demands accountability,” Breed said in a statement. “We fund a wide range of services, and we want to help people get the care they need but under current state law, local governments lack tools to compel people into treatment. This initiative aims to create more accountability and help get people to accept the treatment and services they need.”  

To combat the open air drug dealings in the Tenderloin district, California Gov. Gavin Newsom began pulling officers from the California highway patrol to make arrests, Breitbart News reported.

Keep reading

House Approves Psychedelic Research And Marijuana Labeling Amendments As Part Of Spending Bills

The U.S. House of Representatives has voted to approve a series of psychedelics and marijuana amendments as part of spending bills, and a Democratic congressman is again seeking to revise separate measures to end cannabis testing for federal workers.

On the same day that a Senate committee passed a marijuana banking bill, the House took up amendments to appropriations legislation that were recently cleared for floor consideration by the Rules Committee.

Both psychedelics measures were attached to a spending bill covering the Department of Defense (DOD) in voice votes on Wednesday.

One, sponsored by Reps. Morgan Luttrell (R-TX) and Dan Crenshaw (R-TX), would provide $15 million in funding for DOD to carry out “Psychedelic Medical Clinical Trials.” The second amendment, from Crenshaw alone, lays the parameters for the trials, which would involve active duty service members with post-traumatic stress disorder (PTSD) or traumatic brain injuries (TBI). The Defense Health Agency would need to send a report to Congress with its findings.

Notably, a Democratic congresswoman argued against the proposal, citing DOD concerns about trials involving active duty service members.

Luttrell said ahead of the voice vote on his amendment that he can “personally attest to the benefits in treating post-traumatic stress, traumatic brain injury and chronic traumatic encephalopathy through the use of psychedelic substances.” The congressman, who is a military veteran, has previously disclosed his own experience with psychedelic-assisted therapy.

“There’s a stigma that exists within the [House] that I believe stems from a lack of education experience around the clinical use of plant-based, or psychedelic, medications,” he said. “I understand that when many of my colleagues hear the word ‘psychedelics,’ they think of mushrooms and so on. This isn’t what we are talking about today.”

Keep reading